Greater activation of vital oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes a further hallmark of HGSC,nine and we hypothesise that inhibiting ribosome biogenesis can offer a good cancer therapeutic option.ten In truth, We now have proven encouraging responses Using the ribosomal RNA gene (rDNA